» Articles » PMID: 16515969

Outcome of Renal Tumors in Young Adults

Overview
Journal J Urol
Publisher Wolters Kluwer
Specialty Urology
Date 2006 Mar 7
PMID 16515969
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: Sporadic RCC is rare in young adults. We retrospectively reviewed the outcomes of patients 20 to 40 years old at our institution.

Materials And Methods: Between 1975 and 2004, 2,710 patients were treated surgically for renal masses at our institution. We found 120 patients (4.4%) 20 to 40 years old. We analyzed the clinical presentation, pathological characteristics and outcome of these patients, and compared it to patients older than 40 years.

Results: The mean age of 120 young adults was 34.1 years (range 20.4 to 39.8). Symptomatic presentation was documented in 49.5% of patients. RCC was found in 87 (72.5%) young adults. Young patients generally had a higher rate of organ confined tumors than patients older than 40 years (73.6% vs 59.3%, p <0.05). Histopathological characteristics, tumor size, lymph node metastases and distant metastatic disease did not differ significantly in young and older patients. Women were significantly more likely to have benign lesions (41% vs 20%, p <0.05). Mean followup for 120 patients was 80.6 months and 15 of 87 patients with RCC (17.2%) died of tumor related causes (mean followup 27.5 months). The 10-year cancer specific survival rate was 78% in young adults and 68% in older patients (p = 0.22). Multivariate Cox regression analysis revealed lymph node metastases and tumor differentiation grade as independent prognostic parameters in young patients.

Conclusions: Young patients are more likely to have symptomatic tumors at presentation. Nevertheless, they have more favorable pathological features and a definite trend to superior disease specific survival following surgical treatment. Organ sparing surgery should be considered in young women since benign lesions are frequent found in this population.

Citing Articles

The risk of solid organ tumors in patients with chronic kidney disease: A narrative review of literature.

Al-Qudimat A, Altahtamoun S, Kilic F, Al-Zoubi R, Al Zoubi M Heliyon. 2024; 10(13):e32822.

PMID: 39035535 PMC: 11259794. DOI: 10.1016/j.heliyon.2024.e32822.


A population-based study on incidence trends of kidney and renal pelvis cancers in the United States over 2000-2020.

Mousavi S, Najafi M, Aslani A, Fazlollahi A, Yekta Z, Sadri M Sci Rep. 2024; 14(1):11294.

PMID: 38760399 PMC: 11101446. DOI: 10.1038/s41598-024-61748-2.


Optimal management of renal cell carcinoma in octogenarians: Retrospective analysis using updated Korean Renal Cell Carcinoma (KORCC) database.

Kim J, Jung G, Kwak C, Jeong C, Kang S, Hong S PLoS One. 2023; 18(3):e0283483.

PMID: 36996119 PMC: 10062612. DOI: 10.1371/journal.pone.0283483.


Renal Cell Carcinoma as an Incidental Finding in Firefighters: A Case Series.

Geiger K, Wright T, Deters L Cureus. 2020; 12(7):e9259.

PMID: 32821605 PMC: 7431987. DOI: 10.7759/cureus.9259.


Partial and radical nephrectomy in children, adolescents, and young adults: Equivalent readmissions and postoperative complications.

Alkazemi M, Dionise Z, Jiang R, Wolf S, Pomann G, Tracy E J Pediatr Surg. 2019; 54(11):2343-2347.

PMID: 31178166 PMC: 6879817. DOI: 10.1016/j.jpedsurg.2019.05.018.